- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00802763
Performance Proof of the New NORMA-SENSE
December 4, 2008 updated by: Carmel Medical Center
Performance Proof of the New NORMA-SENSE Panty Liner - in-Vivo STUD
This study was designed to validate the color appearance on the newly developed panty liner (NORMA-SENSE).
The NORMA-SENSE liner changes color when worn by the user and comes into contact with vaginal secretion with an elevated pH level, without false positives due to urine remains or incontinence.
The study will also asses the physical comfort in using NORMA-SENSE and the result reading clarity which includes the ability to visualize and interpret the NORMA-SENSE strip results.
Study Overview
Study Type
Observational
Enrollment (Anticipated)
224
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Haifa, Israel
- Lin Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Probability Sample
Study Population
Women, age greater then 18 without symptoms of vaginal infection.
Description
Inclusion Criteria:
- Women, age 18 years or greater without symptoms of vaginal infection.
- Subject is ready to sign the informed consent form.
Exclusion Criteria:
- Subject is unable or unwilling to cooperate with study procedures.
- Subject is currently participating in another clinical study.
- Subject suffers from vaginal bleeding or is menstruating.
- Subject that have had sexual relations within the last 12 hours.
- Subject that applied local antiseptic or antibiotic or vaginal treatment within the last 3 days.
- Subject that applied vaginal douching within 12 hours prior to the visit at the clinic.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
vaginitis
|
Should be used by the clinician.
the test usage will take up to 6 hours.
The result reading will take few second.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
We will asses agreement between the color status of the NORMA-SENSE as reported by the subject after using the panty liner, and the pH measurement with Nitrazine paper.
Time Frame: 1 week
|
1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2009
Primary Completion (Anticipated)
July 1, 2009
Study Completion (Anticipated)
August 1, 2009
Study Registration Dates
First Submitted
December 4, 2008
First Submitted That Met QC Criteria
December 4, 2008
First Posted (Estimate)
December 5, 2008
Study Record Updates
Last Update Posted (Estimate)
December 5, 2008
Last Update Submitted That Met QC Criteria
December 4, 2008
Last Verified
December 1, 2008
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- F-7-28.1-1 VER-2
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.